280 related articles for article (PubMed ID: 15591215)
1. Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia.
Priore Oliva C; Pisciotta L; Li Volti G; Sambataro MP; Cantafora A; Bellocchio A; Catapano A; Tarugi P; Bertolini S; Calandra S
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):411-7. PubMed ID: 15591215
[TBL] [Abstract][Full Text] [Related]
2. APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency.
Calandra S; Priore Oliva C; Tarugi P; Bertolini S
Curr Opin Lipidol; 2006 Apr; 17(2):122-7. PubMed ID: 16531747
[TBL] [Abstract][Full Text] [Related]
3. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.
Marçais C; Verges B; Charrière S; Pruneta V; Merlin M; Billon S; Perrot L; Drai J; Sassolas A; Pennacchio LA; Fruchart-Najib J; Fruchart JC; Durlach V; Moulin P
J Clin Invest; 2005 Oct; 115(10):2862-9. PubMed ID: 16200213
[TBL] [Abstract][Full Text] [Related]
4. Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene.
Priore Oliva C; Carubbi F; Schaap FG; Bertolini S; Calandra S
J Intern Med; 2008 Apr; 263(4):450-8. PubMed ID: 18324930
[TBL] [Abstract][Full Text] [Related]
5. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer of apolipoprotein A-V improves the hypertriglyceridemic phenotype of apoa5 (-/-) mice.
Sharma V; Beckstead JA; Simonsen JB; Nelbach L; Watson G; Forte TM; Ryan RO
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):474-80. PubMed ID: 23329134
[TBL] [Abstract][Full Text] [Related]
7. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride.
Buonuomo PS; Rabacchi C; Macchiaiolo M; Trenti C; Fasano T; Tarugi P; Bartuli A; Bertolini S; Calandra S
J Clin Lipidol; 2017; 11(6):1329-1337.e3. PubMed ID: 28951076
[TBL] [Abstract][Full Text] [Related]
8. Give me A5 for lipoprotein hydrolysis!
Merkel M; Heeren J
J Clin Invest; 2005 Oct; 115(10):2694-6. PubMed ID: 16200205
[TBL] [Abstract][Full Text] [Related]
9. Rare and common variants in LPL and APOA5 in Thai subjects with severe hypertriglyceridemia: A resequencing approach.
Khovidhunkit W; Charoen S; Kiateprungvej A; Chartyingcharoen P; Muanpetch S; Plengpanich W
J Clin Lipidol; 2016; 10(3):505-511.e1. PubMed ID: 27206937
[TBL] [Abstract][Full Text] [Related]
10. Genotype-phenotype relationships in patients with type I hyperlipoproteinemia.
Chokshi N; Blumenschein SD; Ahmad Z; Garg A
J Clin Lipidol; 2014; 8(3):287-95. PubMed ID: 24793350
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and genetic analysis of three patients with severe hypertriglyceridaemia.
Hooper AJ; Kurtkoti J; Hamilton-Craig I; Burnett JR
Ann Clin Biochem; 2014 Jul; 51(Pt 4):485-9. PubMed ID: 24591733
[TBL] [Abstract][Full Text] [Related]
12. Aberrant hetero-disulfide bond formation by the hypertriglyceridemia-associated p.Gly185Cys APOA5 variant (rs2075291).
Sharma V; Witkowski A; Witkowska HE; Dykstra A; Simonsen JB; Nelbach L; Beckstead JA; Pullinger CR; Kane JP; Malloy MJ; Watson G; Forte TM; Ryan RO
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2254-60. PubMed ID: 25127531
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A-V; a potent triglyceride reducer.
Nilsson SK; Heeren J; Olivecrona G; Merkel M
Atherosclerosis; 2011 Nov; 219(1):15-21. PubMed ID: 21831376
[TBL] [Abstract][Full Text] [Related]
14. Homozygosity for a partial deletion of apoprotein A-V signal peptide results in intracellular missorting of the protein and chylomicronemia in a breast-fed infant.
Albers K; Schlein C; Wenner K; Lohse P; Bartelt A; Heeren J; Santer R; Merkel M
Atherosclerosis; 2014 Mar; 233(1):97-103. PubMed ID: 24529129
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.
Martín-Campos JM; Julve J; Roig R; Martínez S; Errico TL; Martínez-Couselo S; Escolà-Gil JC; Méndez-González J; Blanco-Vaca F
Clin Chim Acta; 2014 Feb; 429():61-8. PubMed ID: 24291057
[TBL] [Abstract][Full Text] [Related]
16. Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis.
Xie SL; Chen TZ; Huang XL; Chen C; Jin R; Huang ZM; Zhou MT
PLoS One; 2015; 10(6):e0129488. PubMed ID: 26079787
[TBL] [Abstract][Full Text] [Related]
17. Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?
Jakel H; Nowak M; Helleboid-Chapman A; Fruchart-Najib J; Fruchart JC
Ann Med; 2006; 38(1):2-10. PubMed ID: 16448983
[TBL] [Abstract][Full Text] [Related]
18. Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding.
Dorfmeister B; Zeng WW; Dichlberger A; Nilsson SK; Schaap FG; Hubacek JA; Merkel M; Cooper JA; Lookene A; Putt W; Whittall R; Lee PJ; Lins L; Delsaux N; Nierman M; Kuivenhoven JA; Kastelein JJ; Vrablik M; Olivecrona G; Schneider WJ; Heeren J; Humphries SE; Talmud PJ
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1866-71. PubMed ID: 18635818
[TBL] [Abstract][Full Text] [Related]
19. Modulation of phenotypic expression of APOA5 Q97X and L242P mutations.
Charrière S; Cugnet C; Guitard M; Bernard S; Groisne L; Charcosset M; Pruneta-Deloche V; Merlin M; Billon S; Delay M; Sassolas A; Moulin P; Marçais C
Atherosclerosis; 2009 Nov; 207(1):150-6. PubMed ID: 19447388
[TBL] [Abstract][Full Text] [Related]
20. Severe hypertriglyceridemia in a patient heterozygous for a lipoprotein lipase gene allele with two novel missense variants.
Kassner U; Salewsky B; Wühle-Demuth M; Szijarto IA; Grenkowitz T; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Eur J Hum Genet; 2015 Sep; 23(9):1259-61. PubMed ID: 25585702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
